Skip to main content
Clinical Trials/CTRI/2024/04/065484
CTRI/2024/04/065484Not yet recruitingPhase 4

A comparative study to assess the efficacy of nanobiofusion gel in the treatment of chronic periodontitis in smokers and non-smokers: A clinico-microbiological randomized controlled trial - NI

Dr Leanne Braganca0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1-Systemically healthy participants.
  • 2-Age group: 20–65 years.
  • 3-A minimum of twenty teeth present.
  • 4-Probing pocket depth (PPD) of 5-6mm in two contralateral quadrants.
  • 5-Smoker’s Group: Moderate smokers- 6-10 cigarettes/day & Heavy smokers (More than 11 cigarettes per day)
  • (Jones et al, 2011)

Exclusion Criteria

  • 1-Systemically compromised patients.
  • 2-Patients taking any other medications.
  • 3-Patients with known allergies or hypersensitivity reactions.
  • 4-Pregnant and lactating women.
  • 5-Subjects who underwent periodontal treatment within a period of 6 months.
  • 6-History of antibiotic intake at least 3 months prior.
  • 7-History of use of mouthwashes within 4 weeks before the start of the study.

Investigators

Sponsor
Dr Leanne Braganca

Similar Trials